GlaxoSmithKline has settled a product liability lawsuit which claimed the company's controversial diabetes drug, Avandia, caused the death of a man in 2006.
The lawsuit, which was scheduled to go to trial this week in a Philadelphia court, was filed by the family of James Burford. The lawsuit claimed the cardiovascular safety profile of Avandia was not accurate. The safety of the drug has been debated for a number of years. In September, European regulators ordered the pill be withdrawn from the market, while major restrictions were place on Avandia in the U.S.
GlaxoSmithKline decided to settle the Burford lawsuit and issued a statement saying that "there are many circumstances where a company may determine to resolve certain matters in order to avoid the inherent risks and significant costs of litigation." The company emphasized that it "continues to stand behind the safety and efficacy of Avandia when used appropriately and according to its label.
If you have been harmed by a defective pharmaceutical or medical product, please contact the Madison Defective Prodcuts Lawyers of Habush Habush & Rottier S.C. ®, by calling 800-242-2874.